| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | J01XX01 |
| UNII: | 2N81MY12TE |
| InChI Key | YMDXZJFXQJVXBF-STHAYSLISA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C3H7O4P |
| Molecular Weight | 138.06 |
| AlogP | -0.09 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 70.06 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 8.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | 100-8800 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Staphylococcal Infections | 3 | D013203 | ClinicalTrials |
| Urinary Tract Infections | 3 | D014552 | ClinicalTrials |
| Gonorrhea | 3 | D006069 | ClinicalTrials |
| Pneumonia, Bacterial | 2 | D018410 | ClinicalTrials |
| Neonatal Sepsis | 2 | D000071074 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Pyelonephritis | 2 | D011704 | ClinicalTrials |
| Appendicitis | 2 | D001064 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Pseudomonas Infections | 1 | D011552 | ClinicalTrials |
| Osteomyelitis | 0 | D010019 | ClinicalTrials |
| Infections | 0 | D007239 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 28915 |
| ChEMBL | CHEMBL1757 |
| DrugBank | DB00828 |
| DrugCentral | 1243 |
| EPA CompTox | DTXSID4048480 |
| FDA SRS | 2N81MY12TE |
| Human Metabolome Database | HMDB0014966 |
| Guide to Pharmacology | 10813 |
| KEGG | C06454 |
| PDB | FCN |
| PharmGKB | PA164748039 |
| SureChEMBL | SCHEMBL50951 |
| ZINC | ZINC000001530427 |